Radiopharmacy in Saxony

Radiopharmacy is developing into a key technology in nuclear medicine cancer treatment. Saxony's ecosystem, particularly in the Dresden region, is ideally positioned for this.

Network Contact

Highly automated production of radiopharmaceuticals

International market leaders and innovation drivers

A powerful network of companies and research institutions with a focus on radiopharmaceuticals has been established in Saxony. The growth nucleus was the former GDR core research center, today's HZDR, which met the demand for radio-pharmaceutical preparations even before reunification. It develops new substances for therapy and diagnostics as well as software algorithms for imaging with positron emission tomography (PET) and is working on equipping innovative immunotherapeutics with additional radioactive emitters.

nukliD® - Radiopharmacy Cluster Dresden

nukliD^® is a dynamic network in Dresden that specializes in radiopharmacy and offers a unique combination of expertise in this field throughout Germany. The network innovatively advances nuclear medicine and opens up new perspectives for cancer treatment.

The close cooperation between the partners in the network results in new approaches in nuclear medicine that improve the precision and effectiveness of cancer treatment. In addition, the network is committed to political activities and lobbying for better framework conditions in order to promote and accelerate progress in cancer research and treatment.

nukliD®